Rigel Pharmaceuticals (RIGL) Assets Average (2011 - 2026)

Rigel Pharmaceuticals' Assets Average history runs 16 years deep, the most recent figure standing at $509.1 million for Q1 2026.

• In Q1 2026, Assets Average rose 199.52% year-over-year to $509.1 million; the TTM figure through Mar 2026 stood at $509.1 million (up 199.52% YoY), while the FY2025 annual figure was $338.8 million, up 140.96% from the prior year.
• Assets Average was $509.1 million for Q1 2026 at Rigel Pharmaceuticals, up from $378.1 million in the prior quarter.
• In the past five years, Assets Average ranged from a high of $509.1 million in Q1 2026 to a low of $116.2 million in Q3 2023.
• Historically, Assets Average has averaged $178.4 million across 5 years, with a median of $133.9 million in 2024.
• The sharpest annual moves came in 2022 and 2026: Assets Average slumped 37.23% in 2022, then soared 199.52% in 2026.
• A 5-year view of Assets Average shows it stood at $124.9 million in 2022, then decreased by 6.94% to $116.3 million in 2023, then surged by 30.46% to $151.7 million in 2024, then soared by 149.22% to $378.1 million in 2025, then surged by 34.66% to $509.1 million in 2026.
• The last three Assets Average figures came in at $509.1 million (Q1 2026), $378.1 million (Q4 2025), and $224.6 million (Q3 2025), per Business Quant data.